Perrigo Company (PRGO) - Financial and Strategic SWOT Analysis Review

GlobalData, March 2013, Pages: 41

Summary

Perrigo Company (Perrigo) is one of the leading pharmaceutical companies based in the US. It develops, manufactures and distributes over-the-counter products, generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), infant formulas, and consumer products. The company operates its business through four reportable segments, namely, Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, and API. It also provides consumer products such as cosmetics, toiletries, bar soaps, and detergents. Perrigo operates in China, England, Germany, Mexico, Israel and the US. The company acquired 100% of the shares of PBM Holdings, Inc.

Perrigo Company Key Recent Developments

Feb 01, 2013: Perrigo Reports Revenue Of $883m In Q2 Fiscal 2013
Jan 23, 2013: Perrigo To Invest $192m In Holland Township Facility, Create 400 New Jobs
Jan 22, 2013: Perrigo Launches Brand Version Of Nicorette Mini Nicotine Lozenges
Jan 07, 2013: Perrigo Gains FDA Clearance To Manufacture Three Codex-Compliant Infant Formulas
Nov 07, 2012: Perrigo Reports Revenue Of $769.8m In Q1 Fiscal 2013GDPH4204FSA

This comprehensive SWOT profile of Perrigo Company provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Perrigo Company - Key Facts
Perrigo Company - Key Employees
Perrigo Company - Key Employee Biographies
Perrigo Company - Major Products and Services
Perrigo Company - History
Perrigo Company - Company Statement
Perrigo Company - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Perrigo Company - Business Description
Perrigo Company - SWOT Analysis
SWOT Analysis - Overview
Perrigo Company - Strengths
Strength - Diversified Business Segments
Strength - Broad Product Portfolio
Strength - Operating Efficiency
Perrigo Company - Weaknesses
Weakness - Concentration of Revenues
Perrigo Company - Opportunities
Opportunity - Strategic Acquisitions
Opportunity - Product Sales
Opportunity - Emerging Markets
Opportunity - Rising Healthcare Expenditure in the US
Perrigo Company - Threats
Threat - Intense Competition
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Uncertain R&D Outcomes
Perrigo Company - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Perrigo Company, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Perrigo Company, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Perrigo Company, Recent Deals Summary
Section 5 – Company’s Recent Developments
Perrigo Company, Recent Developments
Feb 01, 2013: Perrigo Reports Revenue Of $883m In Q2 Fiscal 2013
Jan 23, 2013: Perrigo To Invest $192m In Holland Township Facility, Create 400 New Jobs
Jan 22, 2013: Perrigo Launches Brand Version Of Nicorette Mini Nicotine Lozenges
Jan 07, 2013: Perrigo Gains FDA Clearance To Manufacture Three Codex-Compliant Infant Formulas
Nov 07, 2012: Perrigo Reports Revenue Of $769.8m In Q1 Fiscal 2013
Oct 10, 2012: Perrigo Receives FDA Approval To Market Mini Nicotine Lozenges
Aug 16, 2012: Perrigo Reports Revenue Of $3.2 Billion In Fiscal 2012
Jun 21, 2012: Perrigo Plans To Invest $40m In Israel To Expand R&D And Production Of Pharmaceuticals
May 18, 2012: Perrigo Announces FDA Final Approval And Launch Of Store Brand OTC Lansoprazole 15mg Capsules
May 18, 2012: Perrigo Announces FDA Final Approval And Launch Of Store Brand OTC Lansoprazole 15mg Capsules
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Perrigo Company, Key Facts
Perrigo Company, Key Employees
Perrigo Company, Key Employee Biographies
Perrigo Company, Major Products and Services
Perrigo Company, History
Perrigo Company, Subsidiaries
Perrigo Company, Key Competitors
Perrigo Company, Ratios based on current share price
Perrigo Company, Annual Ratios
Perrigo Company, Interim Ratios
Perrigo Company, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Perrigo Company, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Perrigo Company, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Perrigo Company, Performance Chart (2008 - 2012)
Perrigo Company, Ratio Charts
Perrigo Company, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Perrigo Company, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

NBTY, Inc.
Perrigo Company
Taro Pharmaceuticals Industries Ltd.
LNK International Inc.
Guardian Drug Company
AccuMed Inc.

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report